Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Life Science Firms: FDA Improving but Still Not There

(Investor.gov)

A survey of 50 life science companies conducted by the consulting firm PriceWaterhouseCoopers says the companies feel they have better working relationships with the U.S. Food and Drug Administration (FDA), but they say the agency still does not have adequate resources or is up to speed on advancing technology. The survey was sent . . . → Read More: Life Science Firms: FDA Improving but Still Not There

Clinical Data Reported on Parkinson’s Biomarker Candidates

(National Institute of Mental Health)

KineMed Inc., a drug discovery company in Emeryville, California says it recently presented data on a new use of cerebrospinal fluid biomarkers for the monitoring of disease progression and therapeutic interventions in Parkinson’s disease. The company reported the findings at a grant review meeting of the Michael J. Fox . . . → Read More: Clinical Data Reported on Parkinson’s Biomarker Candidates

GSK, Nottinghan Univ. to Collaborate on Green Chemistry

Jubilee Campus (Univ. of Nottingham)

The BBC is reporting that the global drug manufacturer GlaxoSmithKline (GSK) will build a new lab at the University of Nottingham in the U.K. for research and education in cleaner and safer chemistry processes. The proposal is expected to be presented first as a proof-of-concept in 2011, for construction . . . → Read More: GSK, Nottinghan Univ. to Collaborate on Green Chemistry

Trial Shows Drug Effect on ALS Blood Biomarker

(National Institute on Aging, NIH)

Neuraltus Pharmaceuticals in Palo Alto, California said today an early stage clinical trial of its drug NP001 for the treatment of amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease) showed improvement in a blood biomarker associated with the disease with patients taking the drug. ALS is a disease of . . . → Read More: Trial Shows Drug Effect on ALS Blood Biomarker

Aileron Adds Scripps Chemistry Process for Drug Discovery

The Scripps Research Institute in San Diego, California and Aileron Therapeutics in Cambridge, Massachusetts said today (30 November) they agreed to add Scripps Research’s molecular chemistry technology known as “click chemistry” to Aileron’s peptide and protein platforms. The agreement provides Aileron exclusive rights to use click chemistry for therapeutics and non-exclusive rights for diagnostics.

Click . . . → Read More: Aileron Adds Scripps Chemistry Process for Drug Discovery

New Process Replaces Toxic Substances to Make Nanomaterials

(Photos8.com)

A study by a University of Missouri research team in Columbia has found a method that could replace nearly all of the toxic chemicals required to make gold nanoparticles. The ingredient to replace these toxic substances can be found in nearly every kitchen’s spice cabinet: cinnamon. And the researchers found their discovery could . . . → Read More: New Process Replaces Toxic Substances to Make Nanomaterials

Nanomaterial Developed to Detect Excessive Blast Exposure

(Defense.gov)

Investigators at the University of Pennsylvania School of Medicine and School of Engineering and Applied Sciences in Philadelphia have developed a color-changing patch that could be worn by military service members to indicate the strength of exposure to blasts from explosives in the field. The findings are described in the online edition of . . . → Read More: Nanomaterial Developed to Detect Excessive Blast Exposure

Study: Youth Prescriptions Nearly Double Since 1994

(Photos8.com)

Adolescents and young adults are most likely to abuse prescription medications, which after marijuana is their illicit drug of choice. Yet prescription rates for controlled medications have nearly doubled for those age groups in the past 14 years, according to a study published online in the journal Pediatrics.

Overall, a controlled medication was . . . → Read More: Study: Youth Prescriptions Nearly Double Since 1994

Laser Measurement Device Deployed for Europe Wind R&D

Windscanner (Risø DTU)

Denmark’s National Laboratory for Sustainable Energy, known as Risø DTU, has developed a laser-based instrument package to measure conditions at wind power farms, and that device will now be used across Europe at European Energy Research Alliance research stations and commercial installations. Just one of the devices, called a WindScanner (pictured . . . → Read More: Laser Measurement Device Deployed for Europe Wind R&D

Texas Health Center Studying Newborns Strep Test

Group B Strep bacteria (CDC)

The University of Texas Health Science Center at Houston is studying a faster lab test for Group B Strep (GBS), a common cause of life-threatening infections in newborns. The lab test is made by NanoLogix Inc., a biotech company in Hubbard, Ohio.

According to the U.S. Centers for Disease . . . → Read More: Texas Health Center Studying Newborns Strep Test